These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 30046902)
1. Understanding the interactions of diruthenium anticancer agents with amino acids. Nazarov AA; Mendoza-Ferri MG; Hanif M; Keppler BK; Dyson PJ; Hartinger CG J Biol Inorg Chem; 2018 Oct; 23(7):1159-1164. PubMed ID: 30046902 [TBL] [Abstract][Full Text] [Related]
2. Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis, characterization and biological properties. Pernar M; Kokan Z; Kralj J; Glasovac Z; Tumir LM; Piantanida I; Eljuga D; Turel I; Brozovic A; Kirin SI Bioorg Chem; 2019 Jun; 87():432-446. PubMed ID: 30925428 [TBL] [Abstract][Full Text] [Related]
3. Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes. Hu W; Luo Q; Ma X; Wu K; Liu J; Chen Y; Xiong S; Wang J; Sadler PJ; Wang F Chemistry; 2009 Jul; 15(27):6586-94. PubMed ID: 19533706 [TBL] [Abstract][Full Text] [Related]
4. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related]
5. Design of Ru-arene Complexes for Antitumor Drugs. Su W; Li Y; Li P Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728 [TBL] [Abstract][Full Text] [Related]
6. Effect of cysteine thiols on the catalytic and anticancer activity of Ru(II) sulfonyl-ethylenediamine complexes. Chen F; Romero-Canelón I; Habtemariam A; Song JI; Banerjee S; Clarkson GJ; Song L; Prokes I; Sadler PJ Dalton Trans; 2022 Mar; 51(11):4447-4457. PubMed ID: 35226015 [TBL] [Abstract][Full Text] [Related]
7. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands. Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401 [TBL] [Abstract][Full Text] [Related]
8. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands. Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875 [TBL] [Abstract][Full Text] [Related]